When compared to adjacent normal tissues, ZKSCAN3 was found to be markedly overexpressed in several solid tumors, including colorectal cancer, gastric cancer, pancreatic ductal adenocarcinoma (PDAC), and non-small cell lung cancer (NSCLC). Here, ZKSCAN3 is linked to gastric cancer.